➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Baxter
AstraZeneca
McKesson
Medtronic

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

CEFTRIAXONE IN PLASTIC CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Ceftriaxone In Plastic Container patents expire, and when can generic versions of Ceftriaxone In Plastic Container launch?

Ceftriaxone In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in CEFTRIAXONE IN PLASTIC CONTAINER is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Ceftriaxone In Plastic Container

A generic version of CEFTRIAXONE IN PLASTIC CONTAINER was approved as ceftriaxone sodium by ASTRAL on January 20th, 2017.

  Start Trial

Summary for CEFTRIAXONE IN PLASTIC CONTAINER
Drug patent expirations by year for CEFTRIAXONE IN PLASTIC CONTAINER
Recent Clinical Trials for CEFTRIAXONE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme (Australia) Pty LimitedPhase 3
The University of QueenslandPhase 3
Almaza Military Fever HospitalPhase 3

See all CEFTRIAXONE IN PLASTIC CONTAINER clinical trials

Pharmacology for CEFTRIAXONE IN PLASTIC CONTAINER

US Patents and Regulatory Information for CEFTRIAXONE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CEFTRIAXONE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 065224-001 Aug 23, 2005 RX No Yes   Start Trial   Start Trial   Start Trial
Baxter Hlthcare CEFTRIAXONE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 065224-002 Aug 23, 2005 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Colorcon
Medtronic
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.